(Q33706715)

28 July 2017

1 reference

title

Current drug therapy recommendations for the treatment of endometriosis (English)

1 reference

28 July 2017

1 reference

Bergqvist A

1

1 reference

28 July 2017

1 July 1999

1 reference

28 July 2017

1 reference

28 July 2017

58

1 reference

28 July 2017

1

1 reference

28 July 2017

39-50

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958010-00004

28 July 2017

0 references

cites work

Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study

1 reference

12 December 2020

Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up

1 reference

12 December 2020

A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone

1 reference

12 December 2020

Hormone treatment of endometriosis: the estrogen threshold hypothesis

1 reference

12 December 2020

Hormonal regulation of endometriosis and the rationales and effects of gonadotrophin-releasing hormone agonist treatment: a review

1 reference

12 December 2020

Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.

1 reference

12 December 2020

Immunology and endometriosis. Fact, artifact, or epiphenomenon?

1 reference

12 December 2020

The chronological change of vertebral bone loss following oophorectomy using dual energy X-ray absorptiometry: the correlation with specific markers of bone metabolism

1 reference

12 December 2020

Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations

1 reference

12 December 2020

Add-back therapy in the treatment of endometriosis: the European experience.

1 reference

12 December 2020

Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis

1 reference

12 December 2020

Is mild endometriosis a condition occurring intermittently in all women?

1 reference

12 December 2020

Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain

1 reference

12 December 2020

Lipid metabolic changes during hormonal treatment of endometriosis

1 reference

12 December 2020

Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group

1 reference

12 December 2020

Bone turnover and density in healthy women during breastfeeding and after weaning.

1 reference

12 December 2020

Hormonal therapies for endometriosis: implications for bone metabolism

1 reference

12 December 2020

Medical treatment of symptomatic endometriosis

1 reference

12 December 2020

Endometriosis and pelvic pain: relation to disease stage and localization

1 reference

12 December 2020

Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.

1 reference

12 December 2020

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

1 reference

12 December 2020

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol

1 reference

12 December 2020

Bone loss rate in the lumbar spine: a comparison between natural and surgically induced menopause

1 reference

12 December 2020

Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients

1 reference

12 December 2020

Ovarian hormones and the cardiovascular system: recent findings.

1 reference

12 December 2020

Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up

1 reference

12 December 2020

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston) in women with minimal to mild endometriosis

1 reference

12 December 2020

Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain

1 reference

12 December 2020

Hormonal effects of the 300 microgram norethisterone (NET) minipill. I. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration

1 reference

12 December 2020

Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence

1 reference

12 December 2020

Dysmenorrhea is related to the number of implants in endometriosis patients

1 reference

12 December 2020

OPINION: Is mild endometriosis always a disease?

1 reference

12 December 2020

Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered

1 reference

12 December 2020

Regression of endometriosis following shorter treatment with, or lower dose of danazol. Comparison of pre- and post-treatment laparoscopic findings in the Scandinavian multi-center study

1 reference

12 December 2020

Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist.

1 reference

12 December 2020

Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.

1 reference

12 December 2020

Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability

1 reference

12 December 2020

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis

1 reference

12 December 2020

Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel).

1 reference

12 December 2020

A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment.

1 reference

12 December 2020

Biochemical markers of bone turnover in lactating and nonlactating postpartum women

1 reference

12 December 2020

Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study

1 reference

12 December 2020

Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed

1 reference

12 December 2020

Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate

1 reference

12 December 2020

Effects of triptorelin versus placebo on the symptoms of endometriosis

1 reference

12 December 2020

Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial

1 reference

12 December 2020

Evaluation and management of chronic pelvic pain

1 reference

12 December 2020

Progestins for symptomatic endometriosis: a critical analysis of the evidence.

1 reference

12 December 2020

Nafarelin in the treatment of endometriosis. Dose management

1 reference

12 December 2020

Incidence of symptom recurrence after hysterectomy for endometriosis

1 reference

12 December 2020

A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone

1 reference

12 December 2020

Prevalence of endometriosis in asymptomatic women

1 reference

12 December 2020

Pain of endometriosis: effects of nafarelin and danazol therapy.

1 reference

12 December 2020

Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease

1 reference

12 December 2020

Bone density and endometriosis

1 reference

12 December 2020

Is pelvic endometriosis always associated with chronic pain? A retrospective study of 618 cases diagnosed by laparoscopy.

1 reference

12 December 2020

Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain

1 reference

12 December 2020

Endometriosis: what a pain it is.

1 reference

12 December 2020

Is endometriosis a disease?

1 reference

12 December 2020

Endometriosis persisting after castration: clinical characteristics and results of surgical management

1 reference

12 December 2020

1 reference

12 December 2020

Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group

1 reference

12 December 2020

Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density

1 reference

12 December 2020

Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group

1 reference

12 December 2020

Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigms

1 reference

12 December 2020

10.2165/00003495-199958010-00004

Identifiers

DOI

1 reference

PubMed ID

10439928

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10439928